Search results

För oss på TEDDY är säkerhet och trygghet alltid viktigt. Vi följer Folkhälsomyndighetens, Region Skånes och Lunds universitets riktlinjer.Vi håller oss ständigt uppdaterade och anpassar verksamheten utifrån de riktlinjer som finns.Det som gäller för närvarande är att TEDDY-studien fortsätter sin verksamhet som vanligt, förutom:Personalen arbetar inte vid minsta symtom som snuva, hosta eller feber

https://www.teddy.lu.se/artikel/information-om-hur-coronaviruset-covid-19-paverkar-teddy-mottagningarna - 2025-11-23

Två nya artiklar med spännande forskningsresultat finns nu sammanfattade på svenska: Ökar tarmvirusinfektioner risken för celiaki hos små barn? Hur kan virus trigga autoimmun (typ 1) diabetes? Alla TEDDY-studiens resultat samlas under fliken ”Resultat från TEDDY”. 

https://www.teddy.lu.se/artikel/senaste-forskningsresultaten-fran-teddy - 2025-11-23

Nu är TEDDY-studiens årsrapport för 2019 klar. I den kan ni bland annat läsa om vad TEDDY-forskningen kommit fram till under året. Ni kan också läsa om de nya studierna som TEDDY lagt grund för. Årsrapport 2019 (PDF, öppnas i nytt fönster)

https://www.teddy.lu.se/artikel/arsrapport-2019 - 2025-11-23

Approximately 10–15 per cent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and often recur. An international research team led by researchers at Lund University in Sweden has uncovered a way to treat these aggressive tumours through manipulation of the connective tissue cells of the tumour. The researchers are now developing a ne

https://www.tcr.lu.se/article/new-treatment-aggressive-breast-cancer - 2025-11-23

Six LU researchers receive ERC Starting Grants Colourful common wall lizards, an innovative X-ray microscope and advanced research on Alzheimer’s, leukaemia, photographic evidence and the origin of life. Six researchers from Lund University in Sweden have been granted five-year starting grants totalling EUR 9.5 million from the ERC.  Follow this link for full article.Follow this link for Emma Hamm

https://www.tcr.lu.se/article/pi-emma-hammarlund-receives-erc-grant - 2025-11-23

A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Every year, about 800 children in the US are diagnosed with neuroblastoma, an aggressive cancer of the nervous system that most frequently arises in the adrenal glands

https://www.tcr.lu.se/article/promising-treatment-aggressive-childhood-cancer - 2025-11-23

Emma Hammarlund and Sofie Mohlin at TCR, together with two colleagues from Oxford University, have reviewed how oxygen-sensing mechanisms across eukaryotic kingdoms are alike. From a functional perspective, these systems are active at low oxygen and degraded at high, although their scope varies.    2020-11-16_hammarlund_et_al_2020.pdf .

https://www.tcr.lu.se/article/oxygen-sensing-mechanisms-across-eukaryotic-kingdoms-and-their-roles-complex-multicellularity - 2025-11-23

 Big congratulations to PI:s Daniel Bexell Novel treatment for high-risk neuroblastoma, Christer Larsson Mechanisms determining breast cancer cell fate upon death receptor stimulation - apoptosis or a change in phenotype, Ramin Massoumi Targeted therapy against metastatic melanoma and Sofie Mohlin An Embryonic Model in the Search for Childhood Cancer Initiation on receiving grants from Cancerfonde

https://www.tcr.lu.se/article/pis-tcr-receive-cancerfonden-grants - 2025-11-23

SAVE THE DATE for this upcoming event. Dear all, We hope you are all keeping yourselves safe and healthy through this challenging time.We would like to cordially invite you to a digital imaging meeting including short presentations and discussions about existing imaging facilities and the need for development of the imaging infrastructure at Lund University.When and where: 14th of April 2021, betw

https://www.tcr.lu.se/article/coming-lucc-imaging-nuclear-medicineradiology-seminar - 2025-11-23

Big congratulations to PI:s Håkan Axelson Transformation of renal epithelial cells: the nephron and renal cell carcinoma, Anders Bjartell Integration of Biomarkers in Clinical Models for Improved Outcome Prediction and New Therapies in Prostate Cancer, Emma Hammarlund Utilizing the isotopic elemental fingerprint of cancer to understand tumorgenesis and for the development of truly non-invasive dia

https://www.tcr.lu.se/article/pis-tcr-receive-cancerfonden-grants-0 - 2025-11-23

Big congratulations to Alexander Pietras group on receiving ERC grant. Tumor recurrence and therapeutic resistance: exploring and exploiting the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumors.  

https://www.tcr.lu.se/article/alexander-pietras-group-receives-erc-grant - 2025-11-23

Big congratulations to: Alexander Pietras, The irradiated brain tumor microenvironment: Biology and therapeutic tagets, on receiving Senior Investigator Award, and to Paulina Bolivar, in Kristian Pietras group, Integrative single-cell and spatial analyses to reveal micriniche organization in the tumor microenvironment of triple negative breast cancer, on receiving Postdoc grant from Cancerfonden.

https://www.tcr.lu.se/article/new-cancerfonden-grants - 2025-11-23

PI Daniel Bexell has been awarded millions in funding from Åke Wibergs foundation that goes to young PIs in medical research. One of the aims is to find out why some tumors develop resistance to today’s treatment but also to find new treatment strategies. Every year around 20 children in Sweden are diagnosed with Neuroblastoma, most before even turning 5 years of age. It is a rare and complexed tu

https://www.tcr.lu.se/article/millions-funding-pi-daniel-bexell - 2025-11-23

The platelet-derived growth factor (PDGF) signalling pathway is often dysregulated in cancer and PDGF-receptor expression has been linked to unfavourable prognostic factors in breast cancer (e.g. ER negativity, high Ki67 and high grade). This study aimed to evaluate the expression of PDGFRα, PDGFRβ and ligand PDGF-CC in breast cancer in relation to molecular subtypes and prognosis. Methods: Protei

https://www.tcr.lu.se/article/pdgf-pathway-breast-cancer-linked-tumour-aggressiveness-triple-negative-subtype-and-early-recurrence - 2025-11-23

Congratulations to Yvonne Ceders group and to Alexander Pietras group on receiving Cancerfonden grants.

https://www.tcr.lu.se/article/researchers-tcr-receives-cancerfonden-grants - 2025-11-23

Big congratulations to Göran B Jönssons group (Oncology), Kristian Pietras group and Joan Yuans group (Developmental Immunology) on receiving a joint grant from Knut and Alice Wallenbergs Foundation (KAW).   Article about the project via this link (in Swedish).

https://www.tcr.lu.se/article/researcher-tcr-receives-kaw-grant - 2025-11-23

Big congratulations to  Kazi Uddins group on receiving Barncancerfonden grant for "Utveckling av riktade kombinationsterapi och nya verktyg för att förutspå terapi-resistens" and to Alexander Pietras group on receiving Barncancerfonden grant for "Syrebristberoende måltavlor i barngliom och ponsgliom".

https://www.tcr.lu.se/article/researchers-tcr-receive-barncancerfonden-grants - 2025-11-23

Big congratulations on receiving grants from Swedish Research Council (Vetenskapsrådet, VR):Daniel Bexell, Mekanismer och nya behandlingsstrategier mot resistent neuroblastom, and to...Anders Bjartell, Målriktade behandlingar och biomarkörer vid avancerad prostatacancer, and to...Kristian Pietras, Definiering av funktionella cell-nischer i tumörens mikromiljö som mål för precisionsmedicin.

https://www.tcr.lu.se/article/researchers-tcr-receive-swedish-research-council-grants - 2025-11-23

Big congratulations on receiving Cancerfonden grants:Daniel Bexell, Decoding and Targeting Treatment-Resistant Metastatic Neuroblastoma, an to...Christer Larsson, Induction and consequences of interferon expression in breast cancer cells, and to...Ramin Massoumi, Novel preclinical models for treatment of lung cancer. 

https://www.tcr.lu.se/article/researchers-tcr-receive-cancerfonden-grants - 2025-11-23

One ERC-funded postdoc position in Molecular Pediatric Oncology lab, led by PI Daniel Bexell. The group is working with neuroblastoma (NB), a severe childhood cancer. The overall aims are to unravel mechanisms leading to metastasis and treatment resistance of NB, and to test compounds targeting aggressive NB. The post-doc will lead and develop his/her own analyses and projects, and also work in cl

https://www.tcr.lu.se/article/tcr-now-has-two-postdoc-positions-available - 2025-11-23